(Q36577253)

15 August 2017

Blood eosinophils and inhaled corticosteroid/long-acting β-2 agonist efficacy in COPD (English)

1 reference

chronic obstructive pulmonary disease

15 August 2017

1 reference

Ian D Pavord

1

0 references

author name string

Sally Lettis

2

1 reference

15 August 2017

Nicholas Locantore

3

1 reference

15 August 2017

Steve Pascoe

4

1 reference

15 August 2017

Paul W Jones

5

1 reference

15 August 2017

Jadwiga A Wedzicha

6

1 reference

15 August 2017

Neil C Barnes

7

1 reference

15 August 2017

language of work or name

English

0 references

publication date

19 November 2015

1 reference

15 August 2017

1 reference

15 August 2017

71

1 reference

15 August 2017

2

1 reference

15 August 2017

118-125

1 reference

Blood eosinophil counts, exacerbations, and response to the addition of inhaled fluticasone furoate to vilanterol in patients with chronic obstructive pulmonary disease: a secondary analysis of data from two parallel randomised controlled trials

15 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4752631

Systemic biomarkers in the evaluation and management of COPD patients: are we getting closer to clinical application?

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4752631

Blood eosinophils to direct corticosteroid treatment of exacerbations of chronic obstructive pulmonary disease: a randomized placebo-controlled trial

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4752631

Impact of exacerbations on COPD.

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4752631

An overview of the benefits and drawbacks of inhaled corticosteroids in chronic obstructive pulmonary disease

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4752631

COPD exacerbations: definitions and classifications.

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4752631

Sputum eosinophilia predicts benefit from prednisone in smokers with chronic obstructive bronchitis

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4752631

Blood eosinophil guided prednisolone therapy for exacerbations of COPD: a further analysis.

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4752631

Once-daily inhaled fluticasone furoate and vilanterol versus vilanterol only for prevention of exacerbations of COPD: two replicate double-blind, parallel-group, randomised controlled trials.

20 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4752631

Acute exacerbations of chronic obstructive pulmonary disease: identification of biologic clusters and their biomarkers.

20 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4752631

Pneumonia risk in COPD patients receiving inhaled corticosteroids alone or in combination: TORCH study results.

20 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4752631

Effect of fluticasone propionate/salmeterol (250/50 microg) or salmeterol (50 microg) on COPD exacerbations

20 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4752631

The prevention of chronic obstructive pulmonary disease exacerbations by salmeterol/fluticasone propionate or tiotropium bromide

20 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4752631

Eosinophilic airway inflammation and exacerbations of COPD: a randomised controlled trial.

20 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4752631

Combined salmeterol and fluticasone in the treatment of chronic obstructive pulmonary disease: a randomised controlled trial

20 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4752631

Efficacy and safety of budesonide/formoterol in the management of chronic obstructive pulmonary disease

20 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4752631

Effectiveness of fluticasone propionate and salmeterol combination delivered via the Diskus device in the treatment of chronic obstructive pulmonary disease

20 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4752631

Sputum eosinophilia and short-term response to prednisolone in chronic obstructive pulmonary disease: a randomised controlled trial

20 September 2018

1 reference

Crossref

https://api.crossref.org/works/10.1136%2FTHORAXJNL-2015-207021

Real-world characterization and differentiation of the Global Initiative for Chronic Obstructive Lung Disease strategy classification

21 January 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/26585525

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Airway eosinophilia in chronic bronchitis during exacerbations

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/26585525

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Corticosteroid reversibility in COPD is related to features of asthma

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/26585525

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1136/THORAXJNL-2015-207021

1 reference

15 August 2017

1 reference

15 August 2017

1 reference